DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were ...
Clinical utility of measuring steady-state plasma level of lenvatinib in advanced renal cell carcinoma. Initial AXI regimen: 5 mg orally BID (n, %) 285, 95.0 Time from 1L initiation to first AXI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback